Scheepers J J G, van der Peet D L, Veenhof A A F A, Cuesta M A
Department of Surgery, Vrije Universiteit Medical Center (VUmc), Amsterdam, The Netherlands.
Dis Esophagus. 2009;22(1):42-8. doi: 10.1111/j.1442-2050.2008.00898.x.
We studied the influence of circumferential resection margin (CRM) involvement on survival in patients with malignancies of the distal esophagus and gastroesophageal junction. One hundred ten consecutive patients undergoing a laparoscopic or open transhiatal esophagectomy for malignancy of the distal 5 cm of the esophagus, or a Siewert I gastroesophageal junction tumor were analyzed, retrospectively. Only patients with potentially resectable tumors were included. CRM status was defined as clear or involved (microscopic tumor within 1 mm of the resection margin). Statistical analysis was done by means of univariate and multivariate analysis using the Kaplan-Meier method and Cox proportional hazard model. One hundred ten patients were analyzed. Sixty patients underwent open transhiatal esophagectomy, and 50 patients underwent laparoscopic transhiatal esophagectomy. There were 6 (5%) T(1), 18 (16%) T(2), and 86 (89%) T(3) tumors. CRM was clear in 68 (62%) patients and involved in 42 (38%) patients. Median survival in these groups was 50 vs. 20 months (P = 0.000). Since CRM involvement was only seen in T(3) tumors, this group was analyzed in detail. Median survival in the T(3)CRM(-) and T(3)CRM(+) group was 33 vs. 19 months (P = 0.004). For T(3)N(0) tumors, median survival in CRM(-) and CRM(+) was 40 and 22 months, respectively (P = 0.036). Median survival for T(3)N(1) tumors in CRM(-) and CRM(+) was 22 and 13 months, respectively (P = 0.049). Involvement of the circumferential resection margin was found to be an independent prognostic factor on survival in our study. It predicts a poor prognosis in patients with potentially resectable malignancies of the distal 5 cm of the esophagus and Siewert I adenocarcinomas of the gastro esophageal junction.
我们研究了环周切缘(CRM)受累情况对远端食管癌和胃食管交界部恶性肿瘤患者生存的影响。对连续110例因远端食管5cm范围内恶性肿瘤或Siewert I型胃食管交界部肿瘤接受腹腔镜或开放经裂孔食管切除术的患者进行了回顾性分析。仅纳入有可能切除的肿瘤患者。CRM状态定义为切缘阴性或受累(切缘1mm内有微小肿瘤)。采用Kaplan-Meier法和Cox比例风险模型进行单因素和多因素分析。对110例患者进行了分析。60例患者接受了开放经裂孔食管切除术,50例患者接受了腹腔镜经裂孔食管切除术。有6例(5%)T(1)期、18例(16%)T(2)期和86例(89%)T(3)期肿瘤。68例(62%)患者CRM阴性,42例(38%)患者CRM受累。这些组的中位生存期分别为50个月和20个月(P = 0.000)。由于仅在T(3)期肿瘤中观察到CRM受累,因此对该组进行了详细分析。T(3)CRM(-)组和T(3)CRM(+)组的中位生存期分别为33个月和19个月(P = 0.004)。对于T(3)N(0)期肿瘤,CRM(-)组和CRM(+)组的中位生存期分别为40个月和22个月(P = 0.036)。T(3)N(1)期肿瘤在CRM(-)组和CRM(+)组的中位生存期分别为22个月和13个月(P = 0.049)。在我们的研究中,发现环周切缘受累是生存的独立预后因素。它预示着远端食管5cm范围内有可能切除的恶性肿瘤患者以及胃食管交界部Siewert I型腺癌患者预后不良。